Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | PGD | P52209 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| L-Threonic Acid SCHEMBL29945675 | 1.00 | PDE4A (0.64) | PDE4ATSHROR51E2LMNAUSP2 | |
| L-Threonic Acid SCHEMBL6437643 | 0.97 | — | — | |
| L-Threonic Acid SCHEMBL925622 | 0.97 | — | — | |
| L-Threonic Acid SCHEMBL27279909 | 0.97 | PDE4A (0.67) | PDE4ATSHROR51E2LMNAUSP2 | |
| L-Threonic Acid SCHEMBL113115 | 0.97 | — | — | |
| L-Threonic Acid SCHEMBL120198 | 0.97 | — | — | |
| L-Threonic Acid SCHEMBL18614891 | 0.97 | — | — | |
| L-Threonic Acid SCHEMBL16609889 | 0.97 | — | — | |
| L-Threonic Acid SCHEMBL8684453 | 0.94 | PDE4A (0.64) | PDE4ATSHROR51E2LMNAUSP2 | |
| L-Threonic Acid SCHEMBL30463178 | 0.94 | PDE4A (0.64) | PDE4ATSHROR51E2LMNAUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119504413-A | Synthesis method and application of magnesium L-threonate | 浙江天启生化股份有限公司 | 2025-02-25 | — | — | CN | claimed |
| CN-118680276-A | High-calcium low-cholesterol mayonnaise based on high internal phase emulsion and preparation method thereof | 陕西师范大学 | 2024-09-24 | — | — | CN | claimed |
| US-20240300881-A1 | PROCESS FOR PREPARATION OF LITHIUM L-THREONATE AND USE THEREOF | XIXIOXOME BIOTHERAPEUTICS (US) | 2024-09-12 | — | — | US | claimed |
| CN-114224860-B | Glucosamine calcium tablet preparation and preparation method and application thereof | 山东润德生物科技有限公司 | 2023-04-28 | — | — | CN | claimed |
| CN-114224860-A | Glucosamine calcium tablet preparation and preparation method and application thereof | 山东润德生物科技有限公司 | 2022-03-25 | — | — | CN | claimed |
| CN-119504413-A | Synthesis method and application of magnesium L-threonate | 浙江天启生化股份有限公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-119454679-A | Application of L-threonic acid hemicalcium salt in preparing medicine for preventing and/or treating retinal neovascularization related diseases | 深圳市人民医院 | 2025-02-18 | — | — | CN | disclosed |
| CN-118680276-A | High-calcium low-cholesterol mayonnaise based on high internal phase emulsion and preparation method thereof | 陕西师范大学 | 2024-09-24 | — | — | CN | disclosed |
| US-20240300881-A1 | PROCESS FOR PREPARATION OF LITHIUM L-THREONATE AND USE THEREOF | XIXIOXOME BIOTHERAPEUTICS (US) | 2024-09-12 | — | — | US | disclosed |
| CN-117598488-A | Calcium supplementing nutrition and preparation method thereof | 江中食疗科技有限公司 | 2024-02-27 | — | — | CN | disclosed |
| CN-114224860-B | Glucosamine calcium tablet preparation and preparation method and application thereof | 山东润德生物科技有限公司 | 2023-04-28 | — | — | CN | disclosed |
| CN-113205932-B | Low-temperature-resistant anti-pollution-flashover ceramic insulator and manufacturing process thereof | 江西新龙电瓷电器制造有限公司 | 2022-11-15 | — | — | CN | disclosed |
| CN-111334800-B | PCB micro-etching solution and preparation method thereof | 信丰正天伟电子科技有限公司 | 2022-04-29 | — | — | CN | disclosed |
| CN-114224860-A | Glucosamine calcium tablet preparation and preparation method and application thereof | 山东润德生物科技有限公司 | 2022-03-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240300881-A1 | PROCESS FOR PREPARATION OF LITHIUM L-THREONATE AND USE THEREOF | SLC6A6, SLC6A12, OSGEP | PDE4A 4125/4885TSHR 1295/4885OR51E2 4648/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.